*This week we review Dr. Rory Spiegel's EMNerd) blog post, )A Case of Identity Part Two), on dual antiplatelet therapy for ACS and MI. *
Dual antiplatelet therapy, often aspirin + P2Y12 inhibitors, although commonly used, do not affect mortality and have questionable benefit but are associated with risks of bleeding.
*Then, we delve into core content pearls on anticoagulation including aspirin, ibuprofen, and novel oral anticoagulants using Rosenalli ** (Rosen's Emergency Medicine and Tintinalli's Emergency Medicine: A Comprehensive Review Guide) and Goldrank (10th ed) Chapter 60 and EMPractice October 2013 as a guide. *
As always, visit foamcast.org) )for show notes and the generously donated Rosh Review questions.
Thanks y'all!
-Jeremy Faust and Lauren Westafer
